First Time Loading...
I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 150 KRW -0.75% Market Closed
Updated: Jun 10, 2024
Ilyang Pharmaceutical Co Ltd
/
Income Statement
/
Net Income (Common)

Ilyang Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ilyang Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
I
Ilyang Pharmaceutical Co Ltd
KRX:007570
Net Income (Common)
-₩3.4B
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Net Income (Common)
₩124.6B
CAGR 3-Years
9%
CAGR 5-Years
19%
CAGR 10-Years
4%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Income (Common)
-₩32.9B
CAGR 3-Years
49%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Net Income (Common)
₩158.1B
CAGR 3-Years
89%
CAGR 5-Years
39%
CAGR 10-Years
13%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Income (Common)
-₩9.6B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Net Income (Common)
₩16.5B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
24%

See Also

What is Ilyang Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
-3.4B KRW

Based on the financial report for Mar 31, 2024, Ilyang Pharmaceutical Co Ltd's Net Income (Common) amounts to -3.4B KRW.

What is Ilyang Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
7%

ALPHA SPREAD
Join more than 145,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.